Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
44 studies found for:    Open Studies | "Dwarfism"
Show Display Options
Rank Status Study
21 Recruiting Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth Hormone Replacement Therapy
22 Recruiting Chromosome 18 Clinical Research Center
Conditions: Chromosome Aberrations;   Growth Hormone Deficiency;   Delayed Myelination
Interventions: Procedure: Determination of growth hormone status;   Procedure: Measurement of growth, thyroid and sex hormone levels;   Procedure: Behavior and neuropsychometric evaluations;   Procedure: Audiological and ear, nose and throat examination;   Procedure: Magnetic resonance imaging of the brain;   Procedure: Dysmorphology evaluation;   Procedure: Neurology examination;   Procedure: Dental evaluation;   Procedure: Speech pathology evaluation;   Procedure: Psychiatric evaluation;   Procedure: Orthopedic evaluation;   Procedure: Ophthalmologic evaluation;   Procedure: Gastrointestinal evaluation
23 Recruiting Trial to Compare the Efficacy and Safety of NNC0195-0092 With Placebo and Norditropin® FlexPro® in Adults With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Interventions: Drug: NNC0195-0092;   Drug: somatropin;   Drug: placebo
24 Recruiting Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
25 Recruiting A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
Condition: Growth Hormone-Deficiency
Interventions: Drug: TV-1106;   Drug: somatropin
26 Recruiting A Phase 3, Multicenter Study Designed To Evaluate The Efficacy And Safety Of A Long Acting Hgh Product (Mod-4023) In Adult Subjects With Growth Hormone Deficiency
Condition: Adult Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Other: Placebo
27 Recruiting Genetic Causes of Growth Disorders
Conditions: Short Stature;   Growth Disorder
Intervention:
28 Recruiting Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
Conditions: Chronic Myelogenous Leukemia;   Short Stature
Intervention: Drug: Growth Hormone
29 Recruiting Growth Hormone Secretion Following the Anaerobic Exercise
Condition: Short Stature
Intervention: Other: Anaerobic Test
30 Recruiting Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
Condition: Short Stature
Interventions: Drug: Letrozole;   Drug: Anastrozole
31 Unknown  Increlex Treatment of Children With Chronic Liver Disease and Short Stature
Conditions: Growth Failure;   Chronic Liver Disease
Intervention: Drug: Increlex
32 Recruiting A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
Condition: Idiopathic Short Stature
Interventions: Drug: somatropin;   Drug: triptorelin
33 Unknown  Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight
Condition: Fetal Growth Retardation
Intervention: Drug: somatropin (rDNA)
34 Recruiting Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
Condition: Small for Gestational Age Infant
Intervention: Biological: PEG-somatropin
35 Recruiting Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Conditions: Cockayne Syndrome;   Skin Cancer;   Xeroderma Pigmentosum;   Trichothiodystrophy;   Genodermatosis
Intervention:
36 Recruiting Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome
Conditions: Silver Russell Syndrome;   Prader-Willi Syndrome
Interventions: Drug: Anastrozole;   Drug: Placebo
37 Recruiting Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
Condition: Congenital Hypothyroidism
Interventions: Drug: Levothyroxine;   Device: Ultrasound
38 Recruiting Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis.
Condition: Congenital Hypothyroidism
Intervention: Other: Clinical and radiologic exams and blood samples
39 Recruiting A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication
Conditions: Autoimmune Thyroid Disease;   Congenital Hypothyroidism
Intervention:
40 Unknown  The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism
Conditions: Congenital Hypothyroidism;   Hearing Loss
Intervention: Other: Audiometry

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-44) Show next page of results    Last Page
Indicates status has not been verified in more than two years